Crossmark

Curcumin Sensitizes Prolactinoma Cells to Bromocriptine by Activating the ERK/EGR1 and Inhibiting the AKT/GSK-3β Signaling Pathway In Vitro and In Vivo

Crossref DOI link: https://doi.org/10.1007/s12035-021-02541-4

Published Online: 2021-08-31

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tang, Chao

Zhu, Junhao

Yuan, Feng

Yang, Jin

Cai, Xiangming

Ma, Chiyuan https://orcid.org/0000-0002-1710-5955
Funding

Funding for this research was provided by:

the applied basic research programs of science and technology commission foundation of jiangsu province (BE2015684)
License Information

Text and Data Mining valid from 2021-08-31

Version of Record valid from 2021-08-31
More Information

Article History

Received: 21 June 2021

Accepted: 17 August 2021

First Online: 31 August 2021

Declarations

:

: Animal experiments protocols were approved by the Institutional Animal Committee of Jinling Hospital.

: Not applicable

: The authors declare that no competing interests.

Document is current

Any future updates will be listed below